COVID-19 Research Paper Volume 13, Issue 20 pp 23442—23458
Serum amylase elevation is associated with adverse clinical outcomes in patients with coronavirus disease 2019
Figure 5. Timeline of events for 196 COVID-19 patients with hyperamylasemia. Amylase level at the termination time was extracted within 5 days before discharge or death, and 67 patients with no available data.